Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 51 entries
Sorted by: Best Match Show Resources per page
T-Cadherin Expression in the Epidermis and Adnexal Structures of Normal Skin.

Dermatopathology (Basel, Switzerland)

Buechner S, Erne P, Resink TJ.
PMID: 27904857
Dermatopathology (Basel). 2016 Oct 21;3(4):68-78. doi: 10.1159/000451024. eCollection 2016.

BACKGROUND: T-cadherin is an atypical glycosylphosphatidylinositol-anchored member of the cadherin superfamily of adhesion molecules. The role of T-cadherin in biology of the skin is poorly understood. Expression of T-cadherin in basal keratinocytes and dermal blood vessels of the healthy...

Cite
Buechner S, Erne P, Resink TJ. T-Cadherin Expression in the Epidermis and Adnexal Structures of Normal Skin. Dermatopathology (Basel). 2016;3(4):68-78doi: 10.1159/000451024.
Buechner, S., Erne, P., & Resink, T. J. (2016). T-Cadherin Expression in the Epidermis and Adnexal Structures of Normal Skin. Dermatopathology (Basel, Switzerland), 3(4), 68-78. https://doi.org/10.1159/000451024
Buechner, Stanislaw, et al. "T-Cadherin Expression in the Epidermis and Adnexal Structures of Normal Skin." Dermatopathology (Basel, Switzerland) vol. 3,4 (2016): 68-78. doi: https://doi.org/10.1159/000451024
Buechner S, Erne P, Resink TJ. T-Cadherin Expression in the Epidermis and Adnexal Structures of Normal Skin. Dermatopathology (Basel). 2016 Oct 21;3(4):68-78. doi: 10.1159/000451024. eCollection 2016. PMID: 27904857; PMCID: PMC5121566.
Copy Download .nbib Format: NLM
Chronic thromboembolic pulmonary hypertension.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Reesink HJ, Kloek JJ, Bresser P.
PMID: 25696637
Neth Heart J. 2006 Jun;14(6):219-224.

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rapidly progressive and deadly disease, resulting from incomplete resolution of acute pulmonary embolism. Historically, the incidence of CTEPH was significantly underestimated but it may be as high as 3.8% following acute pulmonary...

Cite
Reesink HJ, Kloek JJ, Bresser P. Chronic thromboembolic pulmonary hypertension. Neth Heart J. 2006;14(6):219-224
Reesink, H. J., Kloek, J. J., & Bresser, P. (2006). Chronic thromboembolic pulmonary hypertension. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 14(6), 219-224.
Reesink, H J, et al. "Chronic thromboembolic pulmonary hypertension." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 14,6 (2006): 219-224.
Reesink HJ, Kloek JJ, Bresser P. Chronic thromboembolic pulmonary hypertension. Neth Heart J. 2006 Jun;14(6):219-224. PMID: 25696637; PMCID: PMC2557259.
Copy Download .nbib Format: NLM
Super and Nonresponders to Catheter Ablation for Atrial Fibrillation: A Quality-of-Life Assessment Using Patient Reported Outcomes.

Circulation. Arrhythmia and electrophysiology

Farwati M, Wazni OM, Tarakji KG, Diab M, Scandinaro A, Amin M, Zmaili M, Bazarbashi N, Dikilitas O, Nakagawa H, Kuroda S, Kanj M, Dresing TJ, Callahan TD, Bhargava M, Baranowski B, Rickard J, Cantillon DJ, Tchou PJ, Saliba WI, Hussein AA.
PMID: 34279998
Circ Arrhythm Electrophysiol. 2021 Aug;14(8):e009938. doi: 10.1161/CIRCEP.121.009938. Epub 2021 Jul 19.

[Figure: see text].

Cite
Farwati M, Wazni OM, Tarakji KG, et al. Super and Nonresponders to Catheter Ablation for Atrial Fibrillation: A Quality-of-Life Assessment Using Patient Reported Outcomes. Circ Arrhythm Electrophysiol. 2021;14(8):e009938doi: 10.1161/CIRCEP.121.009938.
Farwati, M., Wazni, O. M., Tarakji, K. G., Diab, M., Scandinaro, A., Amin, M., Zmaili, M., Bazarbashi, N., Dikilitas, O., Nakagawa, H., Kuroda, S., Kanj, M., Dresing, T. J., Callahan, T. D., Bhargava, M., Baranowski, B., Rickard, J., Cantillon, D. J., Tchou, P. J., Saliba, W. I., & Hussein, A. A. (2021). Super and Nonresponders to Catheter Ablation for Atrial Fibrillation: A Quality-of-Life Assessment Using Patient Reported Outcomes. Circulation. Arrhythmia and electrophysiology, 14(8), e009938. https://doi.org/10.1161/CIRCEP.121.009938
Farwati, Medhat, et al. "Super and Nonresponders to Catheter Ablation for Atrial Fibrillation: A Quality-of-Life Assessment Using Patient Reported Outcomes." Circulation. Arrhythmia and electrophysiology vol. 14,8 (2021): e009938. doi: https://doi.org/10.1161/CIRCEP.121.009938
Farwati M, Wazni OM, Tarakji KG, Diab M, Scandinaro A, Amin M, Zmaili M, Bazarbashi N, Dikilitas O, Nakagawa H, Kuroda S, Kanj M, Dresing TJ, Callahan TD, Bhargava M, Baranowski B, Rickard J, Cantillon DJ, Tchou PJ, Saliba WI, Hussein AA. Super and Nonresponders to Catheter Ablation for Atrial Fibrillation: A Quality-of-Life Assessment Using Patient Reported Outcomes. Circ Arrhythm Electrophysiol. 2021 Aug;14(8):e009938. doi: 10.1161/CIRCEP.121.009938. Epub 2021 Jul 19. PMID: 34279998.
Copy Download .nbib Format: NLM
Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients.

ERJ open research

de Roos MP, Kilsdonk ID, Hekking PW, Peringa J, Dijkstra NG, Kunst PWA, Bresser P, Reesink HJ.
PMID: 33718488
ERJ Open Res. 2021 Mar 08;7(1). doi: 10.1183/23120541.00737-2020. eCollection 2021 Jan.

BACKGROUND: In the coronavirus disease 2019 (COVID-19) pandemic, rapid clinical triage is crucial to determine which patients need hospitalisation. We hypothesised that chest computed tomography (CT) and alveolar-arterial oxygen tension ratio (A-a) gradient may be useful to triage these...

Cite
de Roos MP, Kilsdonk ID, Hekking PW, et al. Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients. ERJ Open Res. 2021;7(1)doi: 10.1183/23120541.00737-2020.
de Roos, M. P., Kilsdonk, I. D., Hekking, P. W., Peringa, J., Dijkstra, N. G., Kunst, P. W. A., Bresser, P., & Reesink, H. J. (2021). Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients. ERJ open research, 7(1), . https://doi.org/10.1183/23120541.00737-2020
de Roos, Marlise P, et al. "Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients." ERJ open research vol. 7,1 (2021). doi: https://doi.org/10.1183/23120541.00737-2020
de Roos MP, Kilsdonk ID, Hekking PW, Peringa J, Dijkstra NG, Kunst PWA, Bresser P, Reesink HJ. Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients. ERJ Open Res. 2021 Mar 08;7(1). doi: 10.1183/23120541.00737-2020. eCollection 2021 Jan. PMID: 33718488; PMCID: PMC7898029.
Copy Download .nbib Format: NLM
Demonstration of a narrow energy spread, ∼0.5  GeV electron beam from a two-stage laser wakefield accelerator.

Physical review letters

Pollock BB, Clayton CE, Ralph JE, Albert F, Davidson A, Divol L, Filip C, Glenzer SH, Herpoldt K, Lu W, Marsh KA, Meinecke J, Mori WB, Pak A, Rensink TC, Ross JS, Shaw J, Tynan GR, Joshi C, Froula DH.
PMID: 21867013
Phys Rev Lett. 2011 Jul 22;107(4):045001. doi: 10.1103/PhysRevLett.107.045001. Epub 2011 Jul 18.

Laser wakefield acceleration of electrons holds great promise for producing ultracompact stages of GeV scale, high-quality electron beams for applications such as x-ray free electron lasers and high-energy colliders. Ultrahigh intensity laser pulses can be self-guided by relativistic plasma...

Cite
Pollock BB, Clayton CE, Ralph JE, et al. Demonstration of a narrow energy spread, ∼0.5  GeV electron beam from a two-stage laser wakefield accelerator. Phys Rev Lett. 2011;107(4):045001doi: 10.1103/PhysRevLett.107.045001.
Pollock, B. B., Clayton, C. E., Ralph, J. E., Albert, F., Davidson, A., Divol, L., Filip, C., Glenzer, S. H., Herpoldt, K., Lu, W., Marsh, K. A., Meinecke, J., Mori, W. B., Pak, A., Rensink, T. C., Ross, J. S., Shaw, J., Tynan, G. R., Joshi, C., & Froula, D. H. (2011). Demonstration of a narrow energy spread, ∼0.5  GeV electron beam from a two-stage laser wakefield accelerator. Physical review letters, 107(4), 045001. https://doi.org/10.1103/PhysRevLett.107.045001
Pollock, B B, et al. "Demonstration of a narrow energy spread, ∼0.5  GeV electron beam from a two-stage laser wakefield accelerator." Physical review letters vol. 107,4 (2011): 045001. doi: https://doi.org/10.1103/PhysRevLett.107.045001
Pollock BB, Clayton CE, Ralph JE, Albert F, Davidson A, Divol L, Filip C, Glenzer SH, Herpoldt K, Lu W, Marsh KA, Meinecke J, Mori WB, Pak A, Rensink TC, Ross JS, Shaw J, Tynan GR, Joshi C, Froula DH. Demonstration of a narrow energy spread, ∼0.5  GeV electron beam from a two-stage laser wakefield accelerator. Phys Rev Lett. 2011 Jul 22;107(4):045001. doi: 10.1103/PhysRevLett.107.045001. Epub 2011 Jul 18. PMID: 21867013.
Copy Download .nbib Format: NLM
Publisher Correction: Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders.

Nature communications

Nist-Lund CA, Pan B, Patterson A, Asai Y, Chen T, Zhou W, Zhu H, Romero S, Resnik J, Polley DB, Géléoc GS, Holt JR.
PMID: 30737404
Nat Commun. 2019 Feb 08;10(1):734. doi: 10.1038/s41467-019-08716-x.

The original version of this Article contained errors in Fig. 5. In panels i and j the three rightmost x-axis labels inadvertently read 'Tmc1' instead of 'Tmc2'. These errors have been corrected in both the PDF and HTML versions...

Cite
Nist-Lund CA, Pan B, Patterson A, et al. Publisher Correction: Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders. Nat Commun. 2019;10(1):734doi: 10.1038/s41467-019-08716-x.
Nist-Lund, C. A., Pan, B., Patterson, A., Asai, Y., Chen, T., Zhou, W., Zhu, H., Romero, S., Resnik, J., Polley, D. B., Géléoc, G. S., & Holt, J. R. (2019). Publisher Correction: Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders. Nature communications, 10(1), 734. https://doi.org/10.1038/s41467-019-08716-x
Nist-Lund, Carl A, et al. "Publisher Correction: Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders." Nature communications vol. 10,1 (2019): 734. doi: https://doi.org/10.1038/s41467-019-08716-x
Nist-Lund CA, Pan B, Patterson A, Asai Y, Chen T, Zhou W, Zhu H, Romero S, Resnik J, Polley DB, Géléoc GS, Holt JR. Publisher Correction: Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders. Nat Commun. 2019 Feb 08;10(1):734. doi: 10.1038/s41467-019-08716-x. PMID: 30737404; PMCID: PMC6368561.
Copy Download .nbib Format: NLM
Technique for inferring angle change as a function of time for high-current electron beams using a dose-rate monitor array.

The Review of scientific instruments

Renk TJ, Weber BV, Rittersdorf IM, Webb TJ.
PMID: 31779426
Rev Sci Instrum. 2019 Nov 01;90(11):114709. doi: 10.1063/1.5110413.

Intense electron beams striking a high-atomic number target produce high-output pulsed photon fluxes for flash x-ray experiments. Without an external guide field, such beams are subject to the dynamics of high-current electron beam propagation, including changes to electron trajectories...

Cite
Renk TJ, Weber BV, Rittersdorf IM, et al. Technique for inferring angle change as a function of time for high-current electron beams using a dose-rate monitor array. Rev Sci Instrum. 2019;90(11):114709doi: 10.1063/1.5110413.
Renk, T. J., Weber, B. V., Rittersdorf, I. M., & Webb, T. J. (2019). Technique for inferring angle change as a function of time for high-current electron beams using a dose-rate monitor array. The Review of scientific instruments, 90(11), 114709. https://doi.org/10.1063/1.5110413
Renk, T J, et al. "Technique for inferring angle change as a function of time for high-current electron beams using a dose-rate monitor array." The Review of scientific instruments vol. 90,11 (2019): 114709. doi: https://doi.org/10.1063/1.5110413
Renk TJ, Weber BV, Rittersdorf IM, Webb TJ. Technique for inferring angle change as a function of time for high-current electron beams using a dose-rate monitor array. Rev Sci Instrum. 2019 Nov 01;90(11):114709. doi: 10.1063/1.5110413. PMID: 31779426.
Copy Download .nbib Format: NLM
Charge-Exchange Atoms and Ion Source Divergence in a 20 TW Applied-B Ion Diode.

Physical review letters

Bailey JE, Carlson AL, Filuk AB, Johnson DJ, Lake P, Maron Y, Mehlhorn TA, Mix LP, Renk TJ, Stygar WA.
PMID: 10062250
Phys Rev Lett. 1996 Oct 21;77(17):3557-3560. doi: 10.1103/PhysRevLett.77.3557.

No abstract available.

Cite
Bailey JE, Carlson AL, Filuk AB, et al. Charge-Exchange Atoms and Ion Source Divergence in a 20 TW Applied-B Ion Diode. Phys Rev Lett. 1996;77(17):3557-3560doi: 10.1103/PhysRevLett.77.3557.
Bailey, J. E., Carlson, A. L., Filuk, A. B., Johnson, D. J., Lake, P., Maron, Y., Mehlhorn, T. A., Mix, L. P., Renk, T. J., & Stygar, W. A. (1996). Charge-Exchange Atoms and Ion Source Divergence in a 20 TW Applied-B Ion Diode. Physical review letters, 77(17), 3557-3560. https://doi.org/10.1103/PhysRevLett.77.3557
Bailey, et al. "Charge-Exchange Atoms and Ion Source Divergence in a 20 TW Applied-B Ion Diode." Physical review letters vol. 77,17 (1996): 3557-3560. doi: https://doi.org/10.1103/PhysRevLett.77.3557
Bailey JE, Carlson AL, Filuk AB, Johnson DJ, Lake P, Maron Y, Mehlhorn TA, Mix LP, Renk TJ, Stygar WA. Charge-Exchange Atoms and Ion Source Divergence in a 20 TW Applied-B Ion Diode. Phys Rev Lett. 1996 Oct 21;77(17):3557-3560. doi: 10.1103/PhysRevLett.77.3557. PMID: 10062250.
Copy Download .nbib Format: NLM
How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols.

Open forum infectious diseases

Asundi A, Resnik J, Benedict PA, Shin M, Rani Elwy A, Branch-Elliman W.
PMID: 33855102
Open Forum Infect Dis. 2021 Apr 07;8(4):ofab072. doi: 10.1093/ofid/ofab072. eCollection 2021 Apr.

BACKGROUND: Early in the coronavirus disease 2019 (COVID-19) pandemic, there was minimal data to guide treatment, and we lacked understanding of how clinicians translated this limited evidence base for potential therapeutics to bedside care. Our objective was to systematically...

Cite
Asundi A, Resnik J, Benedict PA, et al. How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols. Open Forum Infect Dis. 2021;8(4):ofab072doi: 10.1093/ofid/ofab072.
Asundi, A., Resnik, J., Benedict, P. A., Shin, M., Rani Elwy, A., & Branch-Elliman, W. (2021). How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols. Open forum infectious diseases, 8(4), ofab072. https://doi.org/10.1093/ofid/ofab072
Asundi, Archana, et al. "How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols." Open forum infectious diseases vol. 8,4 (2021): ofab072. doi: https://doi.org/10.1093/ofid/ofab072
Asundi A, Resnik J, Benedict PA, Shin M, Rani Elwy A, Branch-Elliman W. How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols. Open Forum Infect Dis. 2021 Apr 07;8(4):ofab072. doi: 10.1093/ofid/ofab072. eCollection 2021 Apr. PMID: 33855102; PMCID: PMC8026152.
Copy Download .nbib Format: NLM
Can you stand the heat of today's drug discovery?.

Drug discovery today

Rink TJ.
PMID: 10825727
Drug Discov Today. 2000 Jun;5(6):226-227. doi: 10.1016/s1359-6446(00)01494-x.

No abstract available.

Cite
Rink TJ. Can you stand the heat of today's drug discovery?. Drug Discov Today. 2000;5(6):226-227doi: 10.1016/s1359-6446(00)01494-x.
Rink, T. J. (2000). Can you stand the heat of today's drug discovery?. Drug discovery today, 5(6), 226-227. https://doi.org/10.1016/s1359-6446(00)01494-x
Rink. "Can you stand the heat of today's drug discovery?." Drug discovery today vol. 5,6 (2000): 226-227. doi: https://doi.org/10.1016/s1359-6446(00)01494-x
Rink TJ. Can you stand the heat of today's drug discovery?. Drug Discov Today. 2000 Jun;5(6):226-227. doi: 10.1016/s1359-6446(00)01494-x. PMID: 10825727.
Copy Download .nbib Format: NLM
Pulmonary hypertension complicating pulmonary sarcoidosis.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Huitema MP, Grutters JC, Rensing BJWM, Reesink HJ, Post MC.
PMID: 27194118
Neth Heart J. 2016 Jun;24(6):390-399. doi: 10.1007/s12471-016-0847-1.

Pulmonary hypertension (PH) is a severe complication of sarcoidosis, with an unknown prevalence. The aetiology is multifactorial, and the exact mechanism of PH in the individual patient is often difficult to establish. The diagnostic work-up and treatment of PH...

Cite
Huitema MP, Grutters JC, Rensing BJWM, et al. Pulmonary hypertension complicating pulmonary sarcoidosis. Neth Heart J. 2016;24(6):390-399doi: 10.1007/s12471-016-0847-1.
Huitema, M. P., Grutters, J. C., Rensing, B. J. W. M., Reesink, H. J., & Post, M. C. (2016). Pulmonary hypertension complicating pulmonary sarcoidosis. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 24(6), 390-399. https://doi.org/10.1007/s12471-016-0847-1
Huitema, M P, et al. "Pulmonary hypertension complicating pulmonary sarcoidosis." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 24,6 (2016): 390-399. doi: https://doi.org/10.1007/s12471-016-0847-1
Huitema MP, Grutters JC, Rensing BJWM, Reesink HJ, Post MC. Pulmonary hypertension complicating pulmonary sarcoidosis. Neth Heart J. 2016 Jun;24(6):390-399. doi: 10.1007/s12471-016-0847-1. PMID: 27194118; PMCID: PMC4887307.
Copy Download .nbib Format: NLM
When organizational climate is unambiguous, it is also strong.

The Journal of applied psychology

Dickson MW, Resick CJ, Hanges PJ.
PMID: 16551188
J Appl Psychol. 2006 Mar;91(2):351-64. doi: 10.1037/0021-9010.91.2.351.

Several recent studies have addressed the topic of climate strength--the degree to which there is agreement among an organization's members regarding the practices and policies as well as the shared values that characterize the organization. To further investigate antecedents...

Cite
Dickson MW, Resick CJ, Hanges PJ. When organizational climate is unambiguous, it is also strong. J Appl Psychol. 2006;91(2):351-64doi: 10.1037/0021-9010.91.2.351.
Dickson, M. W., Resick, C. J., & Hanges, P. J. (2006). When organizational climate is unambiguous, it is also strong. The Journal of applied psychology, 91(2), 351-64. https://doi.org/10.1037/0021-9010.91.2.351
Dickson, Marcus W, et al. "When organizational climate is unambiguous, it is also strong." The Journal of applied psychology vol. 91,2 (2006): 351-64. doi: https://doi.org/10.1037/0021-9010.91.2.351
Dickson MW, Resick CJ, Hanges PJ. When organizational climate is unambiguous, it is also strong. J Appl Psychol. 2006 Mar;91(2):351-64. doi: 10.1037/0021-9010.91.2.351. PMID: 16551188.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 51 entries